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ABSTRACT
Introduction: Social isolation is common in patients
with psychosis and associated with a number of
negative outcomes. Programmes in which volunteers
provide one-to-one support—often referred to as
befriending—have been reputed to achieve favourable
outcomes. However, trial-based evidence for their
effectiveness is limited.
Methods and analysis: This is a randomised
controlled trial comparing the effects of one-to-one
volunteer support with an active control condition for
patients with psychosis over a 1-year period. Patients
in the intervention group will receive the support of a
volunteer for 1 year, who will meet them weekly and
engage them in social and recreational activities.
Patients in the control group will not receive support
from a volunteer. In both groups, patients will be given
a booklet detailing locally available social activities and
otherwise receive treatment as usual. Patients,
volunteers, clinicians and researchers involved in the
delivery of the intervention will not be blinded to group
assignment, while researchers carrying out data
collection will be blinded. Data collection will be
conducted at baseline, at 6 and 12 months. The
primary outcome is the amount of time spent engaging
in social activities per day. Secondary outcomes
include symptoms, quality of life, self-esteem and
costs of care. Attitudes of volunteers towards mentally
ill people will be assessed. Finally, in-depth interviews
will be conducted with patients and volunteers.
Ethics and dissemination: The study has been
approved by the National Research Ethics Service
(NRES) Committee London—Camden & Kings Cross
(reference 15/LO/0674). The findings of the trial will be
published in open access peer-reviewed journals and in
the National Institute for Health Research (NIHR)
journals library, and presented at scientific
conferences. In addition, findings will be summarised
for a lay audience and circulated to all relevant National
Health Service (NHS) and voluntary organisations.
Trial registration number: ISRCTN14021839;
Pre-results.
BACKGROUND
Social isolation of patients with psychotic dis-
orders remains one of the main challenges
in community mental healthcare. It has been
linked to poorer clinical outcomes with
respect to mental and physical health, life
expectancy, engagement with treatment, and
quality of life.1 2
Over the past decades, both the National
Health Service (NHS) and the independent
sector in the UK have used volunteer
resources to support mental health patients
in a wide range of areas, including so-called
befriending. Although the format of
befriending varies across organisations, it typ-
ically involves volunteers spending recre-
ational time with the patient over a period of
time, so as to provide them with an oppor-
tunity to socialise. This is different to
so-called ‘peer support’ where patients
provide support to one another, and the
effects operating within such interactions
might differ from those employed in
befriending. Volunteers are a valuable asset
to mental healthcare, uniquely complement-
ing service provision where mental health
professionals may fall short. Both clinical and
social gains of volunteer support have been
reported. Patients receiving befriending have
Strengths and limitations of this study
▪ The randomised controlled trial is rigorously
designed to address the gap in evidence regard-
ing the effectiveness and cost-effectiveness of
one-to-one volunteer support for patients with
psychosis.
▪ Experiences with the intervention of patients and
volunteers will be examined.
▪ The findings may inform the practice of volun-
teering programmes for community patients with
psychosis within different types of organisations.
▪ A number of outcomes are assessed. However,
there may be different perspectives on what the
most relevant outcomes of volunteer support
are.
▪ The nature of the study poses a high risk of
unblinding of research interviewers.
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reported short-term reduction of symptoms,3 4 improve-
ments in conﬁdence and self-esteem5 6 and increased
energy and interest in going out.7 However, trial-based
evidence on the effectiveness of these one-to-one
support schemes is limited.
Against this background, we designed a randomised
controlled trial (RCT) aiming to test the effectiveness
and cost-effectiveness of a programme of one-to-one vol-
unteer support for patients with psychosis. The pro-
gramme is referred to as a companion scheme to avoid
the term befriending misleading patients into expecta-
tions of a true friendship where some boundaries to the
relationship are imposed by the scheme.8 The scheme is
based on best practice principles from befriending orga-
nisations gathered in a study in the UK ( J Silvester, S
Priebe, N Giatras, et al.s Reﬂecting on rhetoric and prac-
tice in the use of human resource management with
volunteers. Human Relations in preparation)8 and will
be implemented over a 1-year period. The intervention
will be compared with an active control condition. It is
hypothesised that volunteer input will result in patients’
increased social and recreational activities, beyond those
arising directly from the time spent with the volunteer,
and potentially also be beneﬁcial with respect to social
contacts, symptoms, quality of life and self-esteem.
METHODS
Study setting and design
This is a parallel group exploratory RCT with 1:1 alloca-
tion ratio testing the effectiveness of volunteer support,
speciﬁcally for patients with psychotic disorders with
limited engagement in social activities. The trial com-
pares the intervention, regular one-to-one support from
a volunteer, to an active control condition in which
there is no support from a volunteer. Data are collected
at baseline, 6 and 12 months (ﬁgure 1). Researchers
conducting outcome assessments will be blind to the
allocation of patients. All the statistical analyses will be
conducted blind to the participant allocation. The trial
is conducted within community mental health setting in
the UK.
Participants
Inclusion and exclusion criteria for patients
Inclusion criteria for patients are a diagnosis of
schizophrenia or a related disorder (International
Classiﬁcation of Diseases (ICD)-10: F20-29); engaging in
an average of <60 min per day of social activities, as
assessed by the Time Use Survey (TUS);9 willingness to
receive regular one-to-one input from a volunteer over a
1-year period; working age (18–65 years); capacity to
provide written informed consent; sufﬁcient spoken
English and being in care of a community mental health
team for a minimum of 1 month.
Patients are excluded if they have a severe learning dif-
ﬁculty, or physical disability that would require speciﬁc
skills of a volunteer; have received befriending or peer
support services in the past 2 years; or have a history of
physical violence or abuse posing a risk to the volunteer,
as assessed by the referring clinician.
Inclusion and exclusion criteria for volunteers
Inclusion criteria for volunteers are being at least
18 years of age; willingness to provide regular one-to-one
support to a patient with a psychotic disorder over a
1-year period; sufﬁcient command of English and crim-
inal records showing no major convictions (eg, unspent
convictions of fraud or theft; convictions of violent
assault or sexual offences).
Exclusion criteria are the use of secondary mental
health services as a patient currently or in the last year;
having a professional role in a secondary mental health
service; severe physical disability interfering with social
activities; and insufﬁcient understanding of the responsi-
bilities and characteristics of a volunteer despite having
undergone volunteer training.
Recruitment
Patients
Eligible patients are identiﬁed by blinded researchers
screening caseloads with clinicians in mental health
teams in the community in East London, which began
in July 2015. They are then approached by their clin-
ician and asked whether they are willing to be contacted
by a researcher to learn more about potentially becom-
ing involved in a companion scheme. If they agree, a
meeting is arranged at which adequately trained
researchers in obtaining informed consent provides the
patient with a detailed explanation of the study and a
participant information sheet. If the patient agrees to
participate, they are asked to sign a consent form. Their
demographic information is collected and they are
screened using the TUS. If the patient is found to
engage in more than 60 min of social activities per day
Figure1 Time schedule.
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on average over the previous 4 days, they are informed
that they are not eligible for the study and given £5. If
the patient engages in fewer than 60 min of social activ-
ities per day, a full baseline assessment is conducted,
and they are given £15 for their participation in the
research interview. They receive the same amount for
any subsequent follow-up interview.
Adequate enrolment will be achieved by approaching
a number of community mental health teams across East
London (including the London Boroughs of Hackney,
Newham and Tower Hamlets). Enrolment progress will
be regularly monitored, barriers identiﬁed and if
needed advised sought with the Trial Steering Group.
Volunteers
Volunteers are recruited through advertisement of the
companion scheme on job websites, volunteering web-
sites and the volunteering section of the East London
NHS Foundation Trust website; advertisement in local
newspapers; information stalls at volunteering fairs and
poster displays in local community centres in East
London.
Interested individuals are invited to phone or email
the volunteer coordinator, who provides information
about the companion scheme and its requirements,
including the 12-month commitment and eligibility cri-
teria. They are provided with a participant information
sheet explaining the research linked to the companion
scheme and their role as research participants, and
asked to complete an application form. After completing
the form, they are invited for a meeting with the volun-
teer coordinator. At the start of the meeting, informed
consent to participate in the research is taken and they
complete the baseline assessment. They are informed
that this assessment is for research purposes and that
their answers will not have any bearing on whether or
not they are accepted to participate in the scheme. The
assessment collects demographic information and
assesses attitudes to mental illness, and the person’s self-
esteem. They are given £10 for the completion of the
baseline measures and receive the same amount for any
subsequent follow-up interview.
On completion of the baseline, the volunteer under-
goes an informal, standardised interview carried out by
the volunteer coordinator to assess their suitability for
the scheme. This interview explores their motivation,
empathy, relationship building, organisation and com-
munication skills, identiﬁed as key qualities in volunteers
in an earlier research component of the wider research
programme ( J Silvester. ‘In preparation’). After this
interview, they provide the necessary information for a
Disclosure and Barring Service (DBS) to be undertaken.
Provided that there are no issues with the DBS that
would deem it unsuitable for the volunteer to work with
vulnerable adults, and on receipt of two references in
support of their application, they are accepted to the
scheme.
Planned interventions
Experimental intervention
This consists of individual patients with psychosis being
enrolled in a companion scheme, whereby they are
matched with a volunteer companion, who will provide
one-to-one support on a weekly basis over a 1-year
period. This is in addition to their treatment as usual.
The main aim of the scheme is to gradually develop a
trusting relationship and motivate patient to engage in
social activities within local community. This will involve
chatting over a cup of tea at the beginning and develop
into more active social engagement such as attending
workshops and events available in the local area accord-
ing to patient’s interests. The companion scheme is a
complex intervention comprising the recruitment of
suitable volunteers, their training and supervision
(described below), and the regular contact between
them and the patients. The format of the scheme has
been informed by interviews with participants in existing
befriending schemes (befrienders, befriendees and
coordinators of schemes) as part of the wider research
programme.
For each patient–volunteer pair, the volunteer coord-
inator attempts to create a match based on common
interests and individual preferences, as well as practical
considerations such as distance and mutual availability.
A meeting is arranged to introduce the pair at the
patient’s home, unless the patient wishes for the
meeting to take place elsewhere. This is treated as a ‘test
meeting’, after which the volunteer coordinator con-
ﬁrms with both parties separately that they are willing to
proceed with the match. The volunteer coordinator
facilitates the meeting by explaining the purpose of the
meetings, boundaries and ground rules and establishing
common interests among the two. Both parties are pro-
vided with an activity booklet detailing free or inexpen-
sive facilities and activities available locally (eg, parks,
community centres, libraries, sports, leisure centres, gal-
leries and museums) and are encouraged to pursue
these during their contact. It is reiterated that the pair
should meet weekly for at least 1 hour, and that these
meetings will continue for 1 year, after which they can
decide whether or not they wish to continue to meet,
without being overseen by the companion scheme.
The pair subsequently meet on a one-to-one basis,
without being accompanied. The volunteer coordinator
provides supervision by contacting both parties within
the ﬁrst month and intermittently thereafter to monitor
progress and identify any problems. If either party
wishes to discontinue the match, the coordinator hears
from both parties and attempts to resolve any issues
where possible, and arranges to facilitate a further
meeting between the two. If one or both parties still
wish to discontinue the match, attempts are made to
match both parties with another person, where practic-
ally feasible. If either party wishes to discontinue their
participation in the scheme, the volunteer coordinator
attempts to establish whether anything can be done to
Priebe S, et al. BMJ Open 2016;6:e011582. doi:10.1136/bmjopen-2016-011582 3
Open Access
aid their continued participation, prior to formally with-
drawing them from the scheme.
Every 3 months, all patients and volunteers are invited
for a social meet-up (eg, brunch at a local café, a walk
and picnic in a nearby park) with the aim of facilitating
additional interactions between patients and volunteers.
Patient–volunteer pairs are actively encouraged to meet
with other pairs to facilitate wider networks and reduce
the focus on an exclusively one-to-one relationship.
Volunteer training and supervision
Volunteers deemed suitable for the scheme (see the
Volunteers of Recruitment section above) attend a man-
datory training session across 2 days. The training pro-
vides a comprehensive understanding of the purpose of
the scheme, and of the role of the volunteer. The
importance of encouraging the patient to participate in
local activities outside the home, such as those listed in
the activity booklets, is emphasised throughout. Further
aspects of training include understanding schizophrenia
and related disorders, a questions and answers with a
psychiatrist, a hearing voices simulation, a talk from a
service user with lived experience of schizophrenia,
maintaining conﬁdentiality, procedures for safeguarding
vulnerable people and seeking help in an emergency,
communication and listening skills, and managing
boundaries with the patient. In addition, practical
matters such as claiming travel expenses and points of
contact are addressed. On completion of training, volun-
teers are provided with a volunteer handbook covering
all aspects of their participation in the scheme. Before
meeting the patient with whom they will be matched,
each volunteer is given a mobile phone and SIM card
for communicating with the patient, paid for by the
scheme. They are encouraged to contact the volunteer
coordinator at any time. In the event of the volunteer
reporting challenges in the relationship that cannot be
resolved by the volunteer coordinator, they are offered a
meeting with a consultant psychiatrist to discuss their
concerns.
Active control condition
Patients in the control condition do not receive the
support of a volunteer companion, and continue with
treatment as usual. In addition, a meeting is scheduled
with a member of the research team shortly after alloca-
tion to the control, during which the patient is given an
activity booklet detailing free or inexpensive facilities
and activities available in their locality (as given to
patients and volunteers in the experimental condition).
The main aim of the booklet is to inform patients of
venues for active social engagement (eg, workshops
offered in community centres and libraries, classes at
sports clubs and leisure centres); however, activities with
lower levels of social interactions are also included
(eg, parks, galleries and museums). During the meeting,
patient and researcher discuss the patient’s interests and
the researcher encourages the patient to attend suitable
activities detailed in the booklet. This is intended to
control for the effect of patients in the experimental
group receiving more information about locally available
activities via the volunteer.
Outcomes
The following outcome criteria are measured at all time
points (ie, baseline, 6 and 12 months), unless stated
differently.
Primary outcome
The primary outcome is the amount of time in minutes
per day that is spent engaging in social activities,
on average, over the previous 4 days. It is assessed using
a shortened version of the TUS, developed by the Ofﬁce
for National Statistics (ONS) to examine how the
general population in the UK spend their time. The
measure has been previously used with patients with
schizophrenia.10 The present version excludes any items
related to social media interaction. A period of 4 days
allows sufﬁcient time for increased social activity to be
detected, with reduced risk of recall bias.
Secondary outcomes
▸ The number of social contacts over the previous
4 days is assessed using the 16-item patient-rated
Social Contacts Assessment (SCA; D Giacco,
C Palumbo, N Strappelli, et al. Objective social isola-
tion and loneliness in patients with psychotic and
mood disorders. Compr Psychiatry under review).
▸ Subjective quality of life is assessed using the
Manchester Short Assessment of Quality of Life
(MANSA).11
▸ The objective social situation is assessed using the
Objective Social Outcomes Index (SIX).12
▸ Both patient and volunteer self-esteem are assessed
using the 20-item Self-Esteem Rating Scale—Short
Form (SERS-SF).13
▸ The therapeutic relationship will be assessed using
the Scale to Assess Therapeutic Relationships in
Community Mental Health Care (STAR).14 Only
patients in the intervention arm and their volunteers
will complete this, 6 and 12 months after beginning
the intervention. Patients will complete the patient
version of the scale (STAR-P) while volunteers will
complete an adapted version (STAR-V) of the clin-
ician scale (STAR-C).
▸ Attitudes towards mentally unwell people will be
assessed in volunteers using the Social Distance
Questionnaire;15 and the Community Attitudes
toward the Mentally Ill scale (CAMI).16
Clinical symptoms
▸ Patients’ positive and negative symptomatology is
assessed on the Positive and Negative Syndrome Scale
(PANSS),17 a 30-item observer-rated measure, and the
Clinical Assessment Interview for Negative Symptoms
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(CAINS),18 a 13-item observer-rated measure of nega-
tive symptoms.
▸ Patients’ level of depression is measured using the
Beck Depression Inventory (BDI).19
Costs: Service use and costs are assessed using the
Client Service Receipt Inventory (CSRI).20 Quality of
life-adjusted years (QALYs) are calculated based on the
EQ-5D-5L.21
In addition, demographic information is collected at
baseline. The number of meetings between each volun-
teer–patient pair and the amount of time spent together
during each meeting is documented throughout the
study.
Qualitative data
At the end of the intervention, 20 patients in the inter-
vention group and 20 volunteers will be asked to com-
plete semistructured, in-depth interviews about their
experiences of the scheme. We will employ purposive
sampling to capture patients who completed the inter-
vention as well as those who showed irregular patterns in
meeting with volunteer. The interviews will be audio-
recorded, transcribed and analysed using the thematic
analysis framework proposed by Braun and Clarke.22
Participants will be paid £15 for their participation in
the interviews.
Assessment procedures
All researchers involved in data collection both prior
and after intervention allocation are blinded for the dur-
ation of the trial, while it will not be possible to patients,
volunteers, clinicians and researchers involved in the
intervention delivery to be blinded to the allocation The
only exception to this is data collection for the STAR-P
and STAR-V, as these assess the relationship between the
patient and the volunteer, which applies to the interven-
tion group only. These assessments are carried out via
phone by unblinded researchers involved in the delivery
of the intervention.
There is a considerable risk of researchers becom-
ing unblinded during follow-up assessments due to
patients in the experimental group mentioning activ-
ities with the volunteer. To limit this risk, prior to
each interview, patients receive instructions to avoid
revealing their allocation. In addition, at the end of
the interviews, researchers record their guesses as to
whether patients are in the intervention or the control
group.
There is also a risk that some measures are inﬂated in
the intervention group by the intervention itself, that is,
increased social activity as a direct result of meetings
with the volunteer. To address this, unblinded research-
ers liaise with volunteers to ensure that no meeting takes
place between the patient and the volunteer in the week
prior to the follow-up assessment.
Guidance on assessment where participants provide
ambiguous answers (eg, patients reporting having spent
between 1 and 2 hours engaging in activities) has been
developed and is adhered to by all researchers.
Inter-rater reliability across researchers involved in data
collection is established for PANSS and CAINS prior to
ﬁrst assessment.
All quantitative data are entered into Access databases,
and will be retrieved for data cleaning before statistical
analyses. Any personal information stored in locked cabi-
nets on NHS premises if in paper version, and
encrypted if in electronic version.
RANDOMISATION
Following baseline assessments, eligible patients are ran-
domised either to the intervention condition or the
active control condition, using a 1:1 block design algo-
rithm via the online randomisation site of the registered
Pragmatic Clinical Trials Unit (PCTU) at Queen Mary
University of London. A one-off meeting is then
arranged by an unblinded researcher to inform a
patient of his or her allocation.
PROPOSED SAMPLE SIZE
Previous unpublished work within the wider research
programme surveying 113 patients with psychosis in sec-
ondary care in East London has shown that patients
tend to spend 327 min per week on average engaging in
social activities (SD=480), or ∼45 min per day. Doubling
this to 90 min per day would be equivalent to an effect
size of 0.6 (Cohen’s d). To detect such an effect on a
5% signiﬁcance level with 80% power, data for 84
patients (2×42) are required. Assuming a 20% drop out
rate between baseline and 1-year follow-up (as observed
in similar trials with similar patient populations),23 a
total sample size of 106 is needed.
DATA MONITORING
All data are stored in accordance with the Data
Protection Act 1998 and accessible only to members of
the research team. Patient-identiﬁable data are anon-
ymised and password-protected. The trial has no formal
data monitoring; however, the Trial Steering Committee
will provide input into data monitoring. No interim ana-
lyses will be carried out. No risk to participants is
expected; however, any adverse events occurring during
the study period will be recorded.
STATISTICAL ANALYSIS
Quantitative assessments
All statistical analyses will be described in a statistical
analysis plan, which will be ﬁnalised and agreed prior to
any analysis or unblinding of the data. Outcomes will be
compared between the intervention and control groups
using linear regression models, adjusting for the base-
line score of the given outcome.
All analyses will be conducted under the
intention-to-treat principle, and signiﬁcance testing will
be at the 5% level (two-sided). Results will be presented
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in line with the recommendations given in the
CONSORT statement extension for the reporting of
RCTs.
Sensitivity analysis
Any outlying observations will be checked for data accur-
acy and may be excluded in a sensitivity analysis.
Individuals may drop out of the intervention or be lost
to follow-up. In these cases, assumptions must be made
about their outcome data. One may argue that patients
who drop out are more likely to do so if they do not per-
ceive beneﬁt of the intervention, and most likely would
have ended with a less favourable outcome had they
stayed in treatment. Yet, this is not necessarily so for
patients with severe symptoms of schizophrenia. They
might also tend to drop out when they perceive improve-
ment and no further need for the treatment (in this
trial, meetings with a volunteer), in which case drop
outs would have ended with more favourable outcomes.
Sensitivity analyses for both scenarios will be explored.
Depending on data available, we will also conduct a per
protocol analysis.
The ﬁnal data set will be accessible to the principal
investigator and the trial statisticians.
Economic evaluation
The cost of recruiting, training and supporting volun-
teers will be estimated, and added to costs derived from
the CSRI. This measure will record service use at base-
line and each follow-up, and will combine this informa-
tion with standard unit costs. Total costs will be
compared at each follow-up point, controlling for base-
line costs. A bootstrapped regression model will be used
for this, given that the cost data are likely to be positively
skewed.
Cost-effectiveness will be assessed by combining the
follow-up cost data with the primary outcome measure
and also QALY. The latter will be calculated using
EQ-5D scores and standard weights attached to these.
Incremental costs and outcomes will be used to deﬁne
cost-effectiveness ratios (in the absence of dominance).
Uncertainty around the cost-outcome combinations will
be explored using cost-effectiveness planes, and inter-
pretation will be aided using cost-effectiveness accept-
ability curves.
ETHICS APPROVAL AND DISSEMINATION
Any changes to the protocol will be communicated to
and approved by the Ethics Committee and the sponsor,
and patients as appropriate. The ﬁndings of the trial will
be published in open access peer-reviewed journals and
in the National Institute for Health Research (NIHR)
journals library, and presented at scientiﬁc conferences.
In addition, ﬁndings will be summarised for a lay audi-
ence and circulated to all relevant NHS and voluntary
organisations.
DISCUSSION
The present trial aims to provide evidence of the effect-
iveness and cost-effectiveness of one-to-one volunteer
support for patients with psychosis. The trial is rigorously
designed, including a well-deﬁned and closely moni-
tored intervention with systematic training and supervi-
sion of volunteers, an active control, and blinded
outcome assessment.
Implementing the trial design has a number of chal-
lenges. Patients with psychotic disorders often have high
levels of social withdrawal, but may not necessarily
express a feeling of loneliness. Thus, their motivation to
engage in social activities may be low, and they might
either not be willing to establish a relationship with a vol-
unteer or struggle to continue with regular meetings over
a 1-year period. Matching of individual patients and
volunteers is rather speculative, and there is no published
research evidence available to guide this process. In add-
ition, inﬂuencing the behaviour of volunteers with a view
to improving patient outcomes may be more difﬁcult to
achieve than in trials targeting clinicians’ actions.
There are also various challenges to the evaluation
methodology. The primary outcome of assessing time
spent on social activities might not capture the real
extent of social isolation. The intervention may increase
social activities, but ensuring that this increase is not
inﬂated by the direct contacts with the volunteer may be
difﬁcult. Equally, patients’ opportunity to socialise
further may be restricted by the time spent with the vol-
unteer. Measuring time use over the previous 4 days
rather than the previous week may improve response val-
idity, but reduce outcome variance.
The trial will assess a range of potentially important
outcomes; however, it remains speculative as to what the
most appropriate outcomes are and what effect sizes one
may expect. As such, the trial remains exploratory in its
nature, with the prospect of informing a larger deﬁnitive
trial. The ﬁndings may help not only to test the effective-
ness of the volunteering scheme, but also to understand
better the underlying processes of potential changes in
patients. The qualitative analyses accompanying the trial
will be central to this.
If the trial ﬁndings suggest that one-to-one volunteer
support for patients is effective, a larger trial may be
designed to test effectiveness across different contexts
and settings. Positive ﬁndings would also be a further
reason to organise and support volunteering schemes
which, in the UK, are more often run by voluntary orga-
nisations than NHS. Such schemes may have beneﬁts for
the integration of patients and acceptance of mental dis-
orders in the wider population.
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